GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Resmed RMD · USD

Health Care · Health Care Equipment & Supplies · US listing · 🇺🇸 United States

S&P 500

Compare

235.74

+0.19%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

27 analysts, 1 Nov 2026. The analysts' own views, not ours.

  • 4Strong buy
  • 10Buy
  • 11Hold
  • 1Sell
  • 1Strong sell

Price targets

Brokers' own targets, 1 Nov 2026. Not our view.

Last close 235.74Average target 239.67

Low
213.00
Average
239.67
Median
230.00
High
300.00

Forecasts

Analyst averages for the fiscal years ahead

FY2027FY2028FY2029FY2030
Revenue$5.81bn$6.19bn$6.58bn$7.06bn
Revenue, highest$5.83bn$6.26bn$6.71bn$7.26bn
Revenue, lowest$5.79bn$6.09bn$6.36bn$6.91bn
Earnings per share12.0913.3014.5515.61
Earnings per share, highest12.2113.8415.3816.17
Earnings per share, lowest12.0213.0113.6015.16
Analysts1617118

Earnings against forecasts

Earnings per share by fiscal quarter

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Forecast2.822.752.582.512.382.342.062.09
Reported2.862.812.552.552.372.432.202.08
Difference+1.3%+2.1%-1.2%+1.7%-0.6%+3.9%+6.9%-0.4%

Rating changes

Latest broker notes

  • Wells FargoEqual Weight
  • RBC CapitalSector Perform
  • Piper SandlerNeutral
  • KeybancOverweight
  • MizuhoOutperform
  • CitigroupBuy → Neutral
  • JefferiesHold
  • Wells FargoEqual Weight
  • RBC CapitalOutperform
  • KeybancOverweight
  • Morgan StanleyOverweight → Equal Weight
  • CitigroupBuy

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

9 / 10

Revenue growth 11.9% a year over 10 years. Return on equity 23.1%.

Model fair value

278.64

From earnings 278.64, from revenue 254.42.

Piotroski score

4 / 9

A nine-point test of financial strength, for 30 Jun 2025.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.